Janssen Inc. is a global pharmaceutical company founded in 1953 by Dr. Paul Janssen in Belgium. As a subsidiary of Johnson & Johnson, it is recognized as a leading research-based pharmaceutical company. Janssen is dedicated to developing innovative medicines and healthcare solutions that aim to improve patient outcomes and work towards eliminating diseases.
The company specializes in several therapeutic areas, including hematology, oncology, immunology, neuroscience, pulmonary hypertension, and infectious diseases. Janssen develops a wide range of pharmaceutical products to treat conditions such as mental illnesses, cardiovascular diseases, allergies, gastrointestinal disorders, and various cancers. In addition to drug development, Janssen offers healthcare solutions and patient support programs, reflecting its commitment to enhancing quality of life globally.
Headquartered in Beerse, Belgium, Janssen operates with a strong focus on research and development, leveraging Johnson & Johnson’s resources to discover and market nearly 100 new drugs since its inception. Its primary customers include healthcare providers, hospitals, and patients worldwide who benefit from its innovative therapies and comprehensive healthcare offerings.
Janssen Inc. is a global pharmaceutical company founded in 1953 by Dr. Paul Janssen in Belgium. As a subsidiary of Johnson & Johnson, it is recognized as a leading research-based pharmaceutical company. Janssen is dedicated to developing innovative medicines and healthcare solutions that aim to improve patient outcomes and work towards eliminating diseases.
The company specializes in several therapeutic areas, including hematology, oncology, immunology, neuroscience, pulmonary hypertension, and infectious diseases. Janssen develops a wide range of pharmaceutical products to treat conditions such as mental illnesses, cardiovascular diseases, allergies, gastrointestinal disorders, and various cancers. In addition to drug development, Janssen offers healthcare solutions and patient support programs, reflecting its commitment to enhancing quality of life globally.
Headquartered in Beerse, Belgium, Janssen operates with a strong focus on research and development, leveraging Johnson & Johnson’s resources to discover and market nearly 100 new drugs since its inception. Its primary customers include healthcare providers, hospitals, and patients worldwide who benefit from its innovative therapies and comprehensive healthcare offerings.
